ITOS - Iteos Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITOS is currently covered by 4 analysts with an average price target of $23.05. This is a potential upside of $12.9 (127.09%) from yesterday's end of day stock price of $10.15.

Iteos Therapeutics 's activity chart (see below) currently has 19 price targets and 26 ratings on display. The stock rating distribution of ITOS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 17.98% with an average time for these price targets to be met of 123.25 days.

Highest price target for ITOS is $12, Lowest price target is $9, average price target is $15.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 28-May-2025. First documented stock forecast 18-Aug-2020.

Best performing analysts who are covering ITOS - Iteos Therapeutics :

David Nierengarten Daina Graybosch Swayampakula Ramakanth Christopher Neyor

Currently out of the existing stock ratings of ITOS, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$1.85 (18.23%)

$18

3 months 15 days ago
(28-May-2025)

2/7 (28.57%)

$1.94 (19.28%)

281

Buy

$9

$-1.15 (-11.33%)

$59

3 months 29 days ago
(14-May-2025)

1/3 (33.33%)

$1.4 (18.42%)

14

Buy

$46

3 months 29 days ago
(14-May-2025)

1/10 (10%)

$38.74 (533.61%)

198

Buy

$24

$13.85 (136.45%)

$27

1 years 1 months ago
(12-Aug-2024)

0/4 (0%)

$9.5 (65.52%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITOS (Iteos Therapeutics ) average time for price targets to be met?

On average it took 123.25 days on average for the stock forecasts to be realized with a an average price target met ratio 17.98

Which analyst has the current highest performing score on ITOS (Iteos Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on ITOS (Iteos Therapeutics ) with a proven track record?

CHRISTOPHER NEYOR

Which analyst has the most public recommendations on ITOS (Iteos Therapeutics )?

David Nierengarten works at WEDBUSH and has 7 price targets and 7 ratings on ITOS

Which analyst is the currently most bullish on ITOS (Iteos Therapeutics )?

Christopher Neyor with highest potential upside - $13.85

Which analyst is the currently most reserved on ITOS (Iteos Therapeutics )?

Daina Graybosch with lowest potential downside - -$1.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?